Zoledronic acid for neonatal subcutaneous fat necrosis

Clin Case Rep. 2017 Mar 14;5(5):567-569. doi: 10.1002/ccr3.855. eCollection 2017 May.

Abstract

Subcutaneous fat necrosis (SFN) in infants producing severe hypercalcemia is a life-threatening emergency. Pathophysiology may include enhanced gastrointestinal calcium absorption and bone resorption. We treated an infant with SFN and serum calcium of 15 mg/dL with prednisolone and low-dose zoledronic acid. Serum calcium promptly normalized without rebound hypocalcemia, and redosing of zoledronic acid was not necessary.

Keywords: Failure to thrive; hypercalcemia; neonatal; subcutaneous fat necrosis; zoledronic acid.

Publication types

  • Case Reports